BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25350803)

  • 1. Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients.
    Chu D; Popovic M; Chow E; Cella D; Beaumont JL; Lam H; Nguyen J; Di Giovanni J; Pulenzas N; Bedard G; Bottomley A
    J Comp Eff Res; 2014 Sep; 3(5):523-31. PubMed ID: 25350803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.
    Park J; Shin DW; Yun SJ; Park SW; Jeon SS; Kwak C; Kwon TG; Kim HJ; Ahn H
    Oncology; 2013; 85(5):299-305. PubMed ID: 24217330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
    Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
    Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.
    van Andel G; Bottomley A; Fosså SD; Efficace F; Coens C; Guerif S; Kynaston H; Gontero P; Thalmann G; Akdas A; D'Haese S; Aaronson NK
    Eur J Cancer; 2008 Nov; 44(16):2418-24. PubMed ID: 18774706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate's egg.
    O'Leary E; Drummond FJ; Gavin A; Kinnear H; Sharp L
    Qual Life Res; 2015 Sep; 24(9):2219-30. PubMed ID: 25791618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Quality of Life Subjective Perception by Patients Treated for Prostate Cancer with the EORTC QLQ-C30 Questionnaire and QLQ-PR25 Module.
    Dąbrowska-Bender M; Słoniewski R; Religioni U; Juszczyk G; Słoniewska A; Staniszewska A
    J Cancer Educ; 2017 Sep; 32(3):509-515. PubMed ID: 26614256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study.
    Lebret T; Culine S; Davin JL; Hennequin C; Mignard JP; Moreau JL; Rossi D; Zerbib M; Mahmoudi A; Latorzeff I
    Aging Male; 2014 Jun; 17(2):87-93. PubMed ID: 24576298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
    Popovic M; Nguyen J; Chen E; Di Giovanni J; Zeng L; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Apr; 12(2):213-9. PubMed ID: 22458622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer.
    Tomaszewski KA; Püsküllüoğlu M; Biesiada K; Bochenek J; Nieckula J; Krzemieniecki K
    J Psychosoc Oncol; 2013; 31(2):191-203. PubMed ID: 23514254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary psychometric validation of the Polish version of the EORTC elderly module (QLQ-ELD14).
    Wrazen W; Golec EB; Tomaszewska IM; Walocha E; Dudkiewicz Z; Tomaszewski KA
    Folia Med Cracov; 2014; 54(2):35-45. PubMed ID: 25648308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer.
    van Leeuwen M; Kieffer JM; Efficace F; Fosså SD; Bolla M; Collette L; Colombel M; De Giorgi U; Holzner B; van de Poll-Franse LV; van Poppel H; White J; de Wit R; Osanto S; Aaronson NK; ; ;
    Health Qual Life Outcomes; 2017 May; 15(1):97. PubMed ID: 28490338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
    Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
    Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
    Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
    J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of instruments for measuring quality of life in patients with lung cancer.
    Hollen PJ; Gralla RJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):31-40. PubMed ID: 8610235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
    Roeloffzen EM; Hinnen KA; Battermann JJ; Monninkhof EM; van Roermund JG; van Gellekom MP; Frank SJ; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1322-8. PubMed ID: 19939578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma.
    Chmielowska K; Tomaszewski KA; Pogrzebielski A; Brandberg Y; Romanowska-Dixon B
    Eur J Cancer Care (Engl); 2013 Jan; 22(1):88-96. PubMed ID: 22966840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
    Bedard G; Zeng L; Poon M; Lam H; Lauzon N; Chow E
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):118-23. PubMed ID: 23551978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review.
    Nguyen J; Popovic M; Chow E; Cella D; Beaumont JL; Chu D; DiGiovanni J; Lam H; Pulenzas N; Bottomley A
    J Comp Eff Res; 2015 Mar; 4(2):157-66. PubMed ID: 25825844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the EORTC QLQ-C15-PAL and the FACIT-Pal for assessment of quality of life in patients with advanced cancer.
    Lien K; Zeng L; Nguyen J; Cramarossa G; Culleton S; Caissie A; Lutz S; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):541-7. PubMed ID: 21958099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.